Ad Scientiam Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 64

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Ad Scientiam General Information

Description

Developer of a data collection tool designed to measure and monitor the evolution of serious and disabling diseases to improve patient care. The company's data collection tool is a clinically validated medical application, measuring and monitoring the evolution of serious and disabling diseases on a continuous basis and in real life is essential for better management, enabling patients to track their progress through their treatment.

Contact Information

Website
www.adscientiam.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 38 rue Dunois
  • CEDEX 13
  • 75647 Paris
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ad Scientiam Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 00.000 Completed Generating Revenue
4. Grant 18-Jul-2017 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 05-Jul-2017 00000 00.000 00.000 Completed Generating Revenue
2. Angel (individual) 06-Jun-2016 $923K $923K 00.000 Completed Generating Revenue
1. Spin-Off 01-Jan-2013 Completed Startup
To view Ad Scientiam’s complete valuation and funding history, request access »

Ad Scientiam Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
ABSA 000 00.000000 00000.00 00000.00 00 00000.00 00.000
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
Ordinary 45 $5.625082 $1999.15 $1999.15 1x $1999.15 1.7%
To view Ad Scientiam’s complete cap table history, request access »

Ad Scientiam Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Ad Scientiam Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3511944-A1 Touchscreen-based hand dexterity test Pending 11-Jan-2018 0000000000 0
US-20190209051-A1 Touchscreen-based hand dexterity test Inactive 11-Jan-2018 0000000000 00

Ad Scientiam Executive Team (9)

Name Title Board Seat Contact Info
Matthieu Lamy Chief Executive Officer & President
Nicolas Bandel Ph.D Chief Operating Officer
Térence Brochu Co-Founder & Chief Experience Officer
Loic Carmen Chief Data Officer
Francois de Berry Chief Technical Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Ad Scientiam Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ad Scientiam Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Startup42 Accelerator/Incubator Minority 000 0000 000000 0
To view Ad Scientiam’s complete investors history, request access »

Ready to get started?

Request a free trial